483 Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) Dec 2012

483 Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) Dec 2012

Atul Agrawal FDA, Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) - Punjab, India facility and issued 8 inspectional observations (via FDA 483) on 14 Dec 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 8
  • Inspection end: 14 Dec 2012
  • Location: Punjab, India
  • FEI: 3002807972
Add To Cart